INUS
Straddle Chart

Markets / Mutual funds / Sectoral / Thematic

Mutual fundsSIF

Invesco India Pharma and Healthcare Fund - Direct Plan - Growth

NAVs of 8 Nov 2026

Invesco Mutual Fund · Equity fund · Direct plan · Growth

Sectoral / ThematicDirect · GrowthRisk: Very High
NAV · 6 Nov 2026
₹10.2500 ▲ 2.30%
Invesco Mutual Fund
Fund size₹111 crJuly - September 2026
1-month range₹8.95 – 10.25
1 year–
Expense ratio1.93%direct plan, a year
5 years–a year

What the fund does

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

BenchmarkBSE Healthcare TRI
Launched7 Sept 2026
Fund houseInvesco Mutual Fund
Fund managersAditya Khemani

NAV history

91010 2026-09-102026-09-212026-09-292026-10-082026-10-162026-10-272026-11-04

Returns

1 week
+6.11%avg 5.2%
1 month
+8.35%avg 3.0%

Bars: this plan; the thin mark is the Sectoral / Thematic average (direct plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-4.3+0.7+6.1

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held1315 lines in all
Top 10 stocks75.4%of the fund
Short positions-7.6%sold through derivatives
Net equity79.4%long stocks and derivatives minus shorts

Where the money is

Equity 87.0%Cash & others 13.0%Short -7.6%

Sectors (stocks held)

Healthcare Services
45.6%
Pharmaceuticals & Biotechnology
41.4%

Stocks held 13

HoldingSector / type% of fund
Max Healthcare Institute Limited
INE027H01010		Healthcare Services9.58%
Sun Pharmaceutical Industries Limited
INE044A01036		Pharmaceuticals & Biotechnology8.99%
Sai Life Sciences Limited
INE570L01029		Pharmaceuticals & Biotechnology8.63%
Apollo Hospitals Enterprise Limited
INE437A01024		Healthcare Services8.03%
Manipal Health Enterprises Ltd
INE459N01021		Healthcare Services7.98%
Divi's Laboratories Limited
INE361B01024		Pharmaceuticals & Biotechnology7.85%
Global Health Limited
INE474Q01031		Healthcare Services7.00%
Dr Agarwals Health Care Limited
INE943P01029		Healthcare Services6.32%
Corona Remedies Limited
INE02ZQ01018		Pharmaceuticals & Biotechnology6.13%
Torrent Pharmaceuticals Limited
INE685A01028		Pharmaceuticals & Biotechnology4.93%
Glenmark Pharmaceuticals Limited
INE935A01035		Pharmaceuticals & Biotechnology4.86%
Krishna Institute Of Medical Sciences Limited
INE967H01025		Healthcare Services4.72%
Aster DM Quality Care Limited
INE914M01019		Healthcare Services1.99%

Short positions 1

HoldingSector / type% of fund
Net Receivables / (Payables)–-7.57%

Debt, money market and cash 1

HoldingSector / type% of fund
Triparty Repo–20.56%

From the fund house's monthly portfolio (invescomutualfund.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility19.9%yearly, from daily NAVs
Worst fall-11.39%23 Sept 2026 → 23 Oct 2026
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 10 Sept 2026).

Fund details

Fund size (average AUM, July - September 2026)₹111 cr across all plans · this plan ₹15.00 cr
Fund houseInvesco Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanDirect
OptionGrowth
Expense ratio (TER)Direct 1.93% · Regular 3.81% (5 Nov 2026)
Exit loadExit Load^: For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP), Systematic Transfer Plan (STP) and IDCW Transfer Plan, exit load will be as follows: • if units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% • if units are redeemed/switched-out after 3 months: Nil • Switch between the Plans under the Scheme: Nil ^Exit Load charged, if any, will be credited back to the scheme, net of Goods and Services Tax
Minimum investmentRs. 1,000/- per application and in multiples of Re. 1/- thereafter · additional Rs. 1,000/- per application and in multiples of Re. 1/- thereafter
Scheme code (AMFI)154547
ISININF205KA1BX5
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · IDCW₹10.2500–
Regular · Growth₹10.2200–
Regular · IDCW₹10.2200–

Top Sectoral / Thematic funds (direct plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+39.55%+42.38%
HDFC Defence Fund+20.78%+35.14%
HDFC Pharma and Healthcare Fund+28.23%+31.72%
SBI HEALTHCARE OPPORTUNITIES FUND+22.32%+25.68%
HDFC Transportation and Logistics Fund+9.94%+25.29%
Mirae Asset Healthcare Fund+24.35%+25.21%
UTI - Healthcare Fund+18.81%+24.71%
ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND+11.93%+23.21%
Invesco India Pharma and Healthcare Fund––

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth today?

₹10.2500 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of Invesco India Pharma and Healthcare Fund - Direct Plan - Growth?

Returns appear once enough NAV history is available.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.